Nevertheless, sorting of the endogenous CD27-positive CAR-T cell population yielded a CAR-T preparation that outperformed CD27-negative CAR-T cells in orthotopic glioblastoma xenografts. This evidence concerns the gene CD27 and glioblastoma.